Case Reports
Vol. 7 No. 1 (2018)
https://doi.org/10.4081/vl.2018.7520

Simultaneous presence of massive chyloperitoneum and chylothorax and its successful management

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 24 April 2018
Published: 2 October 2018
984
Views
543
Downloads
185
HTML
chylous ascites, chylothorax, lymphatic injury.
Medicine, Lymphatics

Authors

Mukul Bhattarai
drmukulbhattarai@gmail.com
Department of Internal Medicine, Southern Illinois University, School of Medicine, Springfield, IL, United States.
Tamer Hudali
Department of Internal Medicine, Southern Illinois University, School of Medicine, Springfield, IL, United States.
The incidence of massive chylous ascites and chylothorax after aortofemoral bypass grafting (AFBG) procedure is unknown. Leakage of chyle results in severe malnutrition and infection which can be life threatening. Because of the rarity of disease, the definitive guideline on management of such extensive accumulation of chyle is lacking. We present a case of a 68- year-old gentleman who developed large chylous ascites and chylous pleural effusions causing respiratory distress. His history was significant for aortofemoral bypass graft procedure 8 weeks prior to index presentation. He was successfully managed with chylous fluid drainage, judicious use of diuretics, adherence to a low-fat diet, and supplementation with medium-chain triglycerides.

Downloads

Download data is not yet available.

How to Cite



Simultaneous presence of massive chyloperitoneum and chylothorax and its successful management. (2018). Veins and Lymphatics, 7(1). https://doi.org/10.4081/vl.2018.7520
Copyright (c) 2018 Mukul Bhattarai, Tamer Hudali Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.